Biomarkers in the prediction of contrast media induced nephropathy - the BITCOIN study.
Felix S SeibertAnja HeringhausNikolaos PagonasHenrik RudolfBenjamin RohnFrederic BauerNina TimmesfeldHans-Joachim TrappeNina BabelTimm H WesthoffPublished in: PloS one (2020)
The present study is the largest investigation on the use of urinary biomarkers for CI-AKI risk stratification so far. It shows that NGAL provides prognostic information beyond the glomerular biomarkers eGFR and proteinuria.